Purpose: To report the association of optic disk melanocytoma with systemic hypertension. Cases: Ocular examination of 3 asymptomatic hypertensive patients revealed a pigmented lesion over the optic disk. After clinical examination and radiological evaluation a diagnosis of optic disk melanocytoma was made. One patient had a mild decrease in visual acuity associated with an increase in size of the lesion during the follow-up. Systemic evaluation revealed increased urinary vanillylmandelic acid in all the patients. MRI showed diffuse adrenal hyperplasia while a 131I-MIBG scan showed increased uptake in 1 case. Conclusions: Optic disk melanocytoma is a benign tumor though the lesion may increase in size with the resultant decrease in visual acuity over few years. It may be associated with systemic hypertension secondary to increased levels of catecholamines in the body, which is related to the common neural crest origin of melanocytes, adrenal medullary cells and chromaffin cells.

Zimmerman LE: Melanocytes, melanocytic nevi and melanocytomas. The Jonas S. Friedenwald Memorial Lecture. Invest Ophthalmol 1965;4:11–41.
Joffe L, Shields JA, Osher RH, Gass JDM: Clinical and follow-up studies of melanocytomas of the optic disc. Ophthalmology 1979;86:1067–1078.
Mansour AM, Zimmerman LD, La Piana FG, Beauchamp GR: Clinicopathological findings in growing optic nerve head melanocytoma. Br J Opthalmol 1989;73:410–415.
Meyer D, Ge J, Blinder KJ, Sinrad J, Xu S: Malignant transformation of an optic disk melanocytoma. Am J Ophthalmol 1999;127:710–714.
Sadler TW: Third to eighth week: the embryonic period; in Katz S (ed): Langman’s Medical Embryology, ed 8. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 86–90.
Keane TE, Santamaria PJ, Issa MM: Pheochromocytoma; in Graham SD Jr (ed): Glenn’s Urologic Surgery, ed 5. Philadelphia, Lippincott Raven, pp 27–37.
Walsh TJ, Packer S: Bilateral melanocytoma of the optic nerve associated with intracranial meningioma. Ann Ophthalmol 1971;3:885–888.
Rudy FR, Bates RD, Cimorelli AJ, Hill GS, Engelman K: Adrenal medullary hyperplasia: a clinicopathologic study of four cases. Hum Pathol 1980;11:650–657.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.